From Bench to Bedside: A Triad of Innovation in Gastric Cancer Treatment—Immunotherapies, Gene Therapy and Surgery Unite

Dear Colleagues,

Gastric cancer remains a global health challenge; it is one of the most common malignancies and has one of the highest mortality rates. Commonly, by the time of diagnosis, gastric cancer has already reached an advanced stage. Its asymptomatic nature makes early diagnosis a challenging endeavor, and it is therefore imperative to explore novel diagnostic approaches. The landscape of gastric cancer research is rapidly increasing, focusing on diagnostic modalities, including liquid biopsies and molecular biomarkers with promising results and increased specificity and sensitivity. In tandem with diagnostic innovations, modern medicine has also achieved remarkable progress in therapeutic strategies, encompassing targeted therapies, immunotherapies, and personalized treatment approaches. The integration of these cutting-edge developments has the potential to reshape the management of gastric cancer, offering new hope for patients and clinicians alike. It not only promises to enhance the quality of life of those affected by gastric cancer, but also offers new possibilities in the quest for improved outcomes and, ultimately, a cure. As the boundaries of medical science continue to expand, the outlook for gastric cancer patients brightens, and the path toward a brighter, healthier future becomes increasingly promising.

Dr. Gregory Christodoulidis
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• immunotherapy
• gene therapy
• advanced surgery